The University Hospital Zurich together with IBM® invented an outcome prediction tool based on the IBM Watson technology, the Watson Trauma Pathway Explorer®. This tool is an artificial intelligence to predict three outcome scenarios in polytrauma patients: the Systemic Inflammatory Response Syndrome (SIRS) and sepsis within 21 days as well as death within 72 h. The knowledge of a patient's future under standardized trauma treatment might be of utmost importance. Here, new time-related insights on the C-reactive protein (CRP) and sepsis are presented. Meanwhile, the validated IBM Watson Trauma Pathway Explorer® offers a time-related insight into the most frequent laboratory parameters. In total, 3653 patients were included in the databank used by the application, and ongoing admissions are constantly implemented. The patients were grouped according to sepsis, and the CRP was analyzed according to the point of time at which the value was acquired (1, 2, 3, 4, 6, 8, 12, 24, and 48 h and 3, 4, 5, 7, 10, 14, and 21 days). The differences were analyzed using the Mann-Whitney U-Test; binary logistic regression was used to determine the dependency of prediction, and the Closest Top-left Threshold Method presented time-specific thresholds at which CRP is predictive for sepsis. The data were considered as significant at p < 0.05, all analyses were performed in R. The differences in the CRP value of the non-sepsis and sepsis groups are starting to be significant between 6 and 8 h (p < 0.05) after admission inclusive of post hoc analysis, and the binary logistic regression depicts a similar picture. The level of significance is reached between 6 and 8 h (p < 0.05) after admission. The knowledge of the outcome reflected by the CRP in polytrauma patients improves the surgeon's tactical position to indicate operations to reduce antigenic load and avoid an infectious adverse outcome.

Department of Mathematics ETH Zurich 8092 Zurich Switzerland

Department of Trauma Surgery University Hospital Zurich 8091 Zurich Switzerland

Division of Medical Sciences in Sports Masaryks University 62500 Brno Czech Republic

Zobrazit více v PubMed

Lackner I., Weber B., Baur M., Fois G., Gebhard F., Pfeifer R., Cinelli P., Halvachizadeh S., Lipiski M., Cesarovic N., et al. Complement Activation and Organ Damage After Trauma—Differential Immune Response Based on Surgical Treatment Strategy. Front. Immunol. 2020;11:64. doi: 10.3389/fimmu.2020.00064. PubMed DOI PMC

Relja B., Yang B., Bundkirchen K., Xu B., Köhler K., Neunaber C. Different experimental multiple trauma models induce comparable inflammation and organ injury. Sci. Rep. 2020;10:20185. doi: 10.1038/s41598-020-76499-z. PubMed DOI PMC

Mica L., Niggli C., Bak P., Yaeli A., McClain M., Lawrie C.M., Pape H.C. Development of a Visual Analytics Tool for Polytrauma Patients: Proof of Concept for a New Assessment Tool Using a Multiple Layer Sankey Diagram in a Single-Center Database. World J. Surg. 2020;44:764–772. doi: 10.1007/s00268-019-05267-6. PubMed DOI

Niggli C., Pape H.-C., Niggli P., Mica L. Validation of a Visual-Based Analytics Tool for Outcome Prediction in Polytrauma Patients (WATSON Trauma Pathway Explorer) and Comparison with the Predictive Values of TRISS. J. Clin. Med. 2021;10:2115. doi: 10.3390/jcm10102115. PubMed DOI PMC

Alberts A., Klingberg A., Wessig A.K., Combes C., Witte T., Brand K., Pich A., Neumann K. C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1. Sci. Rep. 2020;10:6391. doi: 10.1038/s41598-020-63318-8. PubMed DOI PMC

Ries W., Torzewski J., Heigl F., Pfluecke C., Kelle S., Darius H., Ince H., Mitzner S., Nordbeck P., Butter C., et al. C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study. Front. Cardiovasc. Med. 2021;8:591714. doi: 10.3389/fcvm.2021.591714. PubMed DOI PMC

Mortensen R.F. C-reactive protein, inflammation, and innate immunity. Immunol. Res. 2001;24:163–176. doi: 10.1385/IR:24:2:163. PubMed DOI

Collins G.S., Reitsma J.B., Altman D.G., Moons K.G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ. 2015;350:g7594. doi: 10.1136/bmj.g7594. PubMed DOI

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Northbrook, August 1991. Crit. Care Med. 1992;20:864–874. doi: 10.1097/00003246-199206000-00025. PubMed DOI

Eda S., Kaufmann J., Roos W., Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J. Clin. Lab. Anal. 1998;12:137–144. doi: 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6. PubMed DOI PMC

Sauaia A., Moore F.A., Moore E.E. Postinjury Inflammation and Organ Dysfunction. Crit. Care Clin. 2017;33:167–191. doi: 10.1016/j.ccc.2016.08.006. PubMed DOI PMC

Keel M., Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691–709. doi: 10.1016/j.injury.2004.12.037. PubMed DOI

Berwin J.T., Pearce O., Harries L., Kelly M. Managing polytrauma patients. Injury. 2020;51:2091–2096. doi: 10.1016/j.injury.2020.07.051. PubMed DOI

IBM WATSON Trauma Pathway Explorer© as a Predictor for Sepsis after Polytrauma - Is Procalcitonin Useful for Identifying Septic Polytrauma Patients?

The Role of Lactate for Sepsis in Polytrauma Patients, a Time related Analysis using the IBM Watson Trauma Pathway Explorer®